Cargando…

Epstein-Barr Virus Reactivation Causing Cholestatic Hepatitis

Infection with Epstein-Barr virus (EBV) is common and associated with a high seroprevalence. It is often asymptomatic, but infectious mononucleosis (IM) is the clinical hallmark of this disease especially among teens. Hepatic involvement during primary EBV infection often results in mild self-resolv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Da Cunha, Teresa, Mago, Sheena, Bath, Roopjeet K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Gastroenterology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146782/ https://www.ncbi.nlm.nih.gov/pubmed/35664414 http://dx.doi.org/10.7759/cureus.24552

Ejemplares similares

Double Trouble: A Primary Epstein-Barr Virus Infection Causing Cholestatic Hepatitis and Hemophagocytic Lymphohistiocytosis
por: Lin, Joanne, et al.
Publicado: (2022)

A Case of Hepatitis B Virus Reactivation Triggered by Acute Epstein-Barr Virus Infection
por: Beran, Azizullah, et al.
Publicado: (2021)

Epstein-Barr Virus Hepatitis Masquerading as Painless Jaundice
por: Adelodun, Anuoluwapo, et al.
Publicado: (2022)

Epstein-Barr Virus Infection with Acute Pancreatitis Associated with Cholestatic Hepatitis
por: Kang, Seok-Jin, et al.
Publicado: (2013)

Unusual Presentation of Epstein-Barr Virus-Associated Cholestatic Hepatitis in an Infant
por: Jadah, Raafat Hammad Seroor, et al.
Publicado: (2021)

Findings of Epstein-Barr Virus Large B-Cell Lymphoma in a Patient With a History of Rectal Adenocarcinoma: A Case Report
por: El Dirani, Mirna, et al.
Publicado: (2023)

Acute cholestatic hepatitis induced by Epstein–Barr virus infection in an adult: a case report
por: Khoo, Anthony
Publicado: (2016)

Severe Cholestatic Drug-Induced Liver Injury With Cephalosporin Use
por: Yang, Kevin, et al.
Publicado: (2022)

Differentiating Delayed Esophageal Clearance From Reflux in Scleroderma
por: Pasumarthi, Anusha, et al.
Publicado: (2020)

Acute Peptic Ulcer Disease Caused by Non-Helicobacter pylori-Helicobacter
por: Da Cunha, Teresa, et al.
Publicado: (2021)

Stress-Induced Epstein-Barr Virus Reactivation
por: Sausen, Daniel G., et al.
Publicado: (2021)

Hepatic Sarcoidosis: An Uncommon Cause of Cirrhosis
por: Ghoneim, Sara, et al.
Publicado: (2019)

Epstein-Barr virus hepatitis can cause transient hepatopulmonary syndrome
por: Ghayumi, Seiyed Mohammad Ali, et al.
Publicado: (2018)

Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin
por: Wu, Chung-Chun, et al.
Publicado: (2017)

Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Hemodialysis Patients at Kano Kidney Center
por: Alkhalifah, Ridha H, et al.
Publicado: (2023)

A Molecular Link between Malaria and Epstein–Barr Virus Reactivation
por: Chêne, Arnaud, et al.
Publicado: (2007)

Clinical and Virological Features of Acute Hepatic Exacerbations in Patients With Chronic Hepatitis B Virus Infection
por: Bestas, Remzi, et al.
Publicado: (2021)

Polyarteritis Nodosa Associated With Hepatitis C Virus Infection
por: Amini, Shayan, et al.
Publicado: (2023)

Colonic Gallstone Ileus: Treatment Challenges
por: Da Cunha, Teresa, et al.
Publicado: (2021)

Anticonvulsant Hypersensitivity Syndrome Associated with Epstein-Barr Virus Reactivation
por: Chang, Jae Yong, et al.
Publicado: (2007)

Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus
por: Gorres, Kelly L., et al.
Publicado: (2016)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Epstein–Barr Virus in Gliomas: Cause, Association, or Artifact?
por: Akhtar, Saghir, et al.
Publicado: (2018)

Hydroxyurea-Induced Acute Pancreatitis
por: Bath, Harjot, et al.
Publicado: (2022)

REACTIVATION OF EPSTEIN-BARR VIRUS AND CYTOMEGALOVIRUS INFECTION IN PATIENTS WITH COVID-19
por: ALMAGUER, ANGELICA, et al.
Publicado: (2022)

Epstein–Barr Virus Reactivation-Induced Immunoglobulin Production: Significance on Autoimmunity
por: Nagata, Keiko, et al.
Publicado: (2020)

Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation
por: Murata, Takayuki, et al.
Publicado: (2021)

Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients
por: Bernal, Keishanne Danielle E., et al.
Publicado: (2023)

Epstein–Barr virus reactivation‐related meningoencephalitis with transverse myelitis in pregnancy
por: Nguyen, Andrew Dang Khai, et al.
Publicado: (2023)

Performance of Non-invasive Biomarkers of Liver Fibrosis Amongst Hispanics and African Americans
por: Akpoigbe, Kesiena, et al.
Publicado: (2023)

Candida Albicans Lung Abscess in an Illicit Drugs User With Hepatitis C Virus Chronic Infection
por: Zippi, Maddalena, et al.
Publicado: (2021)

Revealing Hepatitis B Virus as a Silent Killer: A Call-to-Action for Saudi Arabia
por: Alghamdi, Mohammed, et al.
Publicado: (2021)

Oral Microbiota Alteration and Roles in Epstein-Barr Virus Reactivation in Nasopharyngeal Carcinoma
por: Liao, Ying, et al.
Publicado: (2023)

Resurrecting Epstein–Barr Virus
por: Paganelli, Roberto
Publicado: (2022)

Epstein - Barr virus Pneumonitis
por: McManus, Terence E, et al.
Publicado: (2009)

Epstein–Barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein–barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein-Barr virus and skin
por: Sangueza-Acosta, Martin, et al.
Publicado: (2018)

Epstein-Barr Virus Gastritis
por: Oki, Masayuki, et al.
Publicado: (2017)

Direct-Acting Antivirals in the Treatment of Hepatitis C Virus (HCV)/Human Immunodeficiency Virus (HIV) Co-infected Patients: Real-Life Experience From Nepal
por: KC, Sudhamshu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9v8do01jmnfqe9bpbr1m05li8m